Radioimmunotherapy for liver micrometastases in mice: Pharmacokinetics, dose estimation, and long-term effect

Japanese Journal of Cancer Research

Volumn 90, Issue 3, 1999, Pages 342-348

  Saga, Tsuneo ^a   Sakahara, Harumi ^a   Nakamoto, Yuji ^a   Sato, Noriko ^a   Zhao, Songji ^a   Iida, Yasuhiko ^a   Kuroki, Masahide ^b   Endo, Keigo ^c   Konishi, Junji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Absorbed dose estimation; Carcinoembryonic antigen; Liver metastasis; Monoclonal antibody; Radioimmunotherapy

Indexed keywords

CARCINOEMBRYONIC ANTIBODY; F33 101; F33 104; IODINE 131; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; COLON CANCER; CONTROLLED STUDY; DOSIMETRY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG LIVER LEVEL; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; TUMOR VOLUME;

EID: 0032947824     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00753.x     Document Type: Article

References (25)

1. 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet, 346, 336-340 (1995).
2. Kaminski, M. S., Zasadny, K. R., Francis, I. R., Fenner, M. C., Ross, C. W., Milik, A. W., Estes, J., Tuck, M., Regan, D., Fisher, S., Glenn, S. D. and Wahl, R. L. Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. J. Clin. Oncol., 14, 1974-1981 (1996).
3. Behr, T. M., Sharkey, R. M., Juweid, M. E., Dunn, R. M., Vagg, R. C., Ying, Z., Zhang, C-H., Swayne, L. C., Vardi, Y., Siegel, J. A. and Goldenberg, D. M. Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG. J. Nucl Med., 38, 858-870 (1997).
4. Sato, N., Saga, T., Sakahara, H., Nakamoto, Y., Zhao, S., Iida, Y., Kuroki, M., Matsuoka, Y. and Konishi, J. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse. J. Nucl. Med., 40 (1999), in press.
5. Vogel, C. A., Galmiche, M. C. and Buchegger, F. Radioimmunotherapy and fractionated radiotherapy of human colon cancer liver metastases in nude mice. Cancer Res., 57, 447-453 (1997).
6. 2. J. Nucl. Med ,37, 1504-1510 (1996).
7. Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A. and Ferrara, N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in mouse model of experimental liver metastasis. J. Clin. Invest., 95, 1789-1797 (1995).
8. Matsuoka, Y., Kuroki, M., Koga, Y., Kuriyama, H., Mori, T. and Kosaki, G. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces. Cancer Res., 42, 2012-2018 (1982).
9. Kuroki, M., Arakawa, F., Higuchi, H., Matsunaga, A., Okamoto, N., Takakura, K. and Matsuoka, Y. Epitope mapping of the carcinoembryonic antigen by monoclonal antibodies and establishment of a new improved radioimmunoassay system. Jpn. J. Cancer Res., 78, 386-396 (1987).
10. Hunter, W. N. and Greenwood, F. C. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature, 194, 495-496 (1962).
11. Lindmo, T., Boven, E., Cuttitta, F., Fedorco, J. and Bunn, P. A., Jr. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods, 72, 77-89 (1984).
12. Saga, T., Weinstein, J. N., Jeong, J. M., Heya, T., Lee, J. T., Le, N., Paik, C. H., Sung, C. and Neumann, R. D. Two-step targeting of experimental lung metastases with biotinylated antibody and radiolabeled streptavidin. Cancer Res., 54, 2160-2165 (1994).
13. Bardies, M. and Chatal, J.-F. Absorbed dose for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres. Phys. Med. Biol., 39, 961-981 (1993).
14. Behr, T. M., Goldenberg, D. M. and Becker, W. S. Radioimmunotherapy of solid tumors: a review "of mice and men," Hybridoma, 16, 101-107 (1997).
15. Behr, T. M., Sharkey, R. M., Juweid, M. E., Dunn, R. M., Ying, Z., Zhang, C-H., Siegel, J. A. and Goldenberg, D. M. Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and anti-mucin monoclonal antibodies. J. Nucl. Med., 38, 409-418 (1997).
16. Buchegger, F., Pelegrin, A., Delaloye, B., Bischof-Delaloye, A. and Mach, J. P. Iodine-131-labeled F(ab')2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice. J. Nucl. Med., 31, 1035-1044 (1990).
17. Hagan, P. L., Halpern, S. E., Dillman, R. O., Shawler, D. L., Johnson, D. E., Chen, A., Krishnan, L., Frincke, J., Bartholomew, R. M., David, G. S. and Carlo, D. Tumor size: effect on monoclonal antibody uptake in tumor models. J. Nucl. Med., 27, 422-427 (1986).
18. Vogel, C. A., Galmiche, M. C., Westermann, P., Sun, L.-Q., Pelegrin, A., Folli, S., Delaloye, A. B., Slosman, D. O., Mach, J.-P. and Buchegger, F. Carcinoembryonic antigen expression, antibody localisation and immunophotodetection of human colon cancer liver metastases in nude mice: a model for radioimmunotherapy. Int. J. Cancer, 67, 294-302 (1996).
19. Fowler, J. F. Radiobiological aspects of low dose rates in radioimmunotherapy. Int. J. Radiat. Oncol. Biol. Phys., 18, 1261-1269 (1990).
20. Kobayashi, H., Sakahara, H., Hosono, M., Yao, Z., Toyama, S., Endo, K. and Konishi, J. Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor. J. Nucl. Med., 35, 1677-1684 (1994).
21. Roffler, R. R., Chan, J. and Yeh, M.-Y. Potentiation of radioimmunotherapy by inhibition of topoisomerase I. Cancer Res., 54, 1276-1285 (1994).
22. Stein, R., Goldenberg, D. M., Thorpe, S. R., Basu, A. and Mattes, M. J. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors. Cancer Res., 55, 3132-3139 (1995).
23. Stein, R., Goldenberg, D. M., Thorpe, S. and Mattes, M. J. Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human non-small-cell carcinoma of the lung. J. Nucl. Med., 38, 391-395 (1997).
24. Humm, J. L. Dosimetric aspects of radiolabeled antibodies for tumor therapy. J. Nucl. Med., 27, 1490-1497 (1986).
25. Dunn, R. M., Juweid, M., Sharkey, R. M., Behr, T. M. and Goldenberg, D. M. Can occult metastases be treated by radioimmunotherapy? Cancer, 80, 2656-2659 (1997).